title: Can co-stimulated tumor immunity be therapeutically efficacious?
authors.affiliation: Bristol-Myers Pharmaceutical Research Institute, Seattle, WA 98121, USA.
authors.forename: K E
authors.initials: KE
authors.lastname: Hellström
authors.forename: I
authors.initials: I
authors.lastname: Hellström
authors.forename: L
authors.initials: L
authors.lastname: Chen
mesh_terms: D000818:Animals; D018122:B7-1 Antigen / Q000494:pharmacology*; D018106:CD28 Antigens / Q000494:pharmacology*; D004357:Drug Synergism; D016233:Immunotherapy, Active; D051379:Mice; D009374:Neoplasms, Experimental / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D018122:B7-1 Antigen; D018106:CD28 Antigens